major
vaccin
licens
control
infecti
diseas
veterinari
speci
today
base
technolog
introduc
jenner
use
live
vaccin
pasteur
use
kill
whole
organ
vaccin
year
ago
respect
yet
former
technolog
stop
sever
success
vaccin
program
develop
much
veterinari
vaccinolog
driven
realiti
exist
rais
product
anim
work
veterinari
practic
make
live
depend
keep
anim
healthi
vaccin
biodefens
emerg
neglect
diseas
reduc
virul
inde
major
live
attenu
vaccin
market
today
gener
approach
van
oirschot
select
mutant
enhanc
expos
pathogen
mutagen
agent
grow
pathogen
low
temperatur
condit
control
specif
gene
mutat
control
extent
attenu
thu
requir
test
individu
passag
agent
final
arriv
level
attenu
accept
final
sinc
mani
mutat
point
mutat
high
probabl
back
mutat
revers
virul
introduc
anim
possibl
best
exampl
abil
revert
virul
polio
viru
oral
polio
viru
given
human
contain
singlepoint
mutat
rapidli
revert
virul
form
upon
replic
vivo
greensfeld
howev
even
potenti
problem
mani
effect
live
vaccin
licens
major
role
diseas
reduct
even
though
safeti
vaccin
concern
fortun
knowledg
pathogen
gene
involv
induc
protect
virul
possibl
target
specif
gene
involv
attenu
delet
entir
gene
pathogen
attenu
organ
use
genet
engin
techniqu
safeti
profil
vaccin
dramat
improv
approach
safer
difficult
acquir
whole
gene
would
lead
revers
modifi
point
mutat
also
possibl
major
vaccin
licens
control
infecti
diseas
veterinari
speci
today
base
technolog
introduc
jenner
use
live
vaccin
pasteur
use
whole
kill
vaccin
year
ago
respect
although
vaccin
use
reduc
econom
loss
industri
primarili
produc
empir
process
littl
knowledg
anim
physiolog
host
respons
vaccin
includ
import
relev
versu
immun
respons
control
infect
import
specif
virul
factor
pathogen
howev
recent
advanc
especi
last
year
genom
proteom
biotechnolog
immunolog
pathogenesi
vaccin
formul
deliveri
dramat
chang
approach
vaccin
develop
result
advanc
believ
next
gener
vaccin
safer
costeffect
histor
live
attenu
vaccin
gener
repeat
passag
pathogen
vitro
differ
condit
randomli
gener
mutant
industri
vaccin
like
insur
polici
protect
event
one
hope
never
happen
exampl
usda
recogn
vari
level
protect
way
allow
label
claim
aid
diseas
control
prevent
diseas
prevent
infect
addit
may
indirect
protect
herd
immun
result
vaccin
suffici
number
anim
given
popul
result
reduct
abil
diseas
transmit
vaccin
individu
percept
vaccin
provid
steril
immun
diseas
agent
establish
infect
wide
held
gener
unfound
larg
unrealist
recent
advanc
especi
last
year
genom
proteom
biotechnolog
immunolog
pathogenesi
vaccin
formul
deliveri
dramat
chang
approach
vaccin
develop
use
optim
vaccin
shown
prevent
diseas
reduc
need
pharmaceut
intervent
improv
health
welfar
anim
indirectli
peopl
well
challeng
develop
optim
vaccin
program
deal
great
divers
exist
within
anim
world
probabl
singl
optim
program
occas
magic
solut
optim
vaccin
program
anim
nonetheless
solid
understand
anim
innat
environment
risk
factor
well
variabl
stress
enabl
develop
tailor
vaccin
schedul
best
meet
need
anim
use
vaccin
anim
health
restrict
protect
morbid
mortal
anim
host
regularli
employ
key
element
public
health
program
appropri
bioprepared
manag
model
strategi
conting
plan
futur
link
protect
diva
vaccin
zoonos
effect
predict
model
deploy
implement
polici
control
prevent
seriou
zoonot
diseas
man
anim
becom
achiev
local
state
nation
level
modul
degre
attenu
import
ensur
adequ
replic
attenu
vaccin
occur
induc
optim
level
protect
immun
caus
patholog
final
advantag
use
live
vaccin
deliv
natur
rout
infect
provid
protect
natur
site
entri
ie
mucos
protect
howev
even
advantag
approach
much
greater
scrutini
regulatori
agenc
less
safe
convent
methodolog
attenu
therebi
ad
significantli
expens
licens
mani
potenti
valuabl
vaccin
need
industri
current
popular
method
attenu
delet
incapacit
entir
gene
requir
replic
howev
also
possibl
introduc
temperaturesensit
ts
mutat
would
reduc
pathogen
abil
replic
temperatur
present
lower
respiratori
tract
thu
vaccin
could
infect
upper
respiratori
tract
induc
immun
limit
replic
lower
respiratori
tract
damag
could
lead
complic
pneumonia
possibl
death
addit
introduc
singl
ts
mutat
one
could
introduc
multipl
ts
mutat
therebi
provid
much
safer
stabl
attenu
current
possibl
convent
ts
mutant
approach
attract
mani
respiratori
infect
especi
influenza
virus
ts
mutant
current
use
control
equin
influenza
townsend
et
al
delet
nonessenti
gene
vaccin
design
reduc
virul
pathogen
howev
also
possibl
make
vaccin
delet
essenti
gene
complet
prevent
replic
vaccin
vivo
type
mutat
result
replic
defect
organ
make
vaccin
total
safe
approach
use
varieti
differ
prototyp
vaccin
principl
behind
approach
possibl
cultur
vaccin
vitro
suppli
element
requir
replic
agent
introduc
vivo
element
absent
agent
undergo
abort
infect
howev
abort
infect
suffici
antigen
produc
induc
immun
type
defect
vaccin
produc
number
differ
organ
variat
replic
defect
vaccin
approach
one
specif
gene
introduc
requir
specif
metabolit
compound
replic
donnenberg
kaper
allow
control
replic
vitro
well
vivo
long
requir
compound
introduc
vaccin
individu
fed
specif
compound
period
time
allow
vaccin
replic
vivo
remov
requir
compound
agent
die
type
approach
easi
introduc
bacteria
make
bacteri
vaccin
type
vaccin
remov
concern
shed
organ
environ
would
rapidli
die
environ
lack
complementari
growth
compon
possibl
greatest
advantag
live
genet
engin
vaccin
fact
vaccin
use
vector
carri
protect
protein
pathogen
thu
possibl
immun
individu
organ
attenu
also
antigen
carri
vector
thu
singl
immun
protect
individu
varieti
diseas
approach
gain
consider
interest
veterinari
biopharmaceut
industri
sinc
would
make
vaccin
product
deliveri
much
econom
singl
vector
carri
multipl
vaccin
manufactur
singl
step
furthermor
interfer
antigen
often
seen
multipl
agent
time
vaccin
current
dozen
viral
vaccin
base
pox
viru
vector
licens
veterinari
medicin
gerdt
et
al
similarli
number
compani
develop
adenovirusbas
vector
reddi
et
al
reddi
et
al
case
poxvirusbas
vector
one
either
use
mammalian
avian
poxvirus
vector
sinc
avian
poxvirus
undergo
abort
replic
mammalian
cell
gain
signific
market
share
licens
thu
safeti
concern
outweigh
genet
engin
concern
recent
report
develop
solid
immun
monkey
ebola
marburg
lassa
viru
follow
singl
immun
vsv
recombin
creat
signific
excit
use
vsv
potenti
vector
jone
et
al
howev
instanc
vector
vaccin
one
alway
concern
impact
preexist
immun
vector
potenti
efficaci
vaccin
possibl
reason
monkey
total
protect
ebola
follow
vsvvector
immun
versu
adenovirusvector
immun
fact
monkey
na
vsv
current
possibl
develop
live
vector
vaccin
use
bacteria
virus
carrier
deliv
natur
rout
infect
mass
administr
aerosol
feed
water
critic
poultri
industri
approach
overcom
need
handl
individu
anim
also
overcom
disadvantag
supernat
contain
rtx
toxin
second
virul
factor
express
specif
physiolog
condit
ie
ironregul
protein
thu
care
must
taken
ensur
bacteria
cultur
appropri
condit
express
put
protect
antigen
potter
sinc
inactiv
vaccin
poorli
immunogen
often
requir
adjuv
enhanc
immun
mani
adjuv
formul
caus
tissu
reaction
see
furthermor
gener
induc
good
humor
immun
respons
minim
cellmedi
mucos
immun
mani
case
later
respons
critic
optim
protect
addit
mani
vaccin
deliv
needl
may
break
remain
anim
long
period
time
pain
anim
concern
consum
might
encount
foreign
object
meat
howev
mani
success
vaccin
use
technolog
continu
use
industri
variat
theme
kill
vaccin
subunit
vaccin
instead
develop
vaccin
contain
antigen
pathogen
possibl
identifi
critic
protein
involv
induc
protect
use
vaccin
theoret
possibl
purifi
protein
convent
produc
vaccin
howev
expens
therefor
much
econom
clone
gene
produc
subunit
vaccin
use
biotechnolog
approach
embark
subunit
vaccin
program
critic
identifi
critic
antigen
incorpor
vaccin
produc
antigen
commerci
set
fortun
knowledg
regard
critic
protein
abil
isol
gene
code
protein
becom
rel
routin
last
decad
thu
protect
antigen
import
infecti
diseas
agent
veterinari
medicin
known
agent
still
need
identifi
put
protect
antigen
use
compar
biolog
genom
identifi
rel
quickli
howev
identif
first
step
vaccin
product
program
antigen
identifi
must
produc
commerci
viabl
system
bacteri
antigen
product
bacteri
system
rel
straightforward
protein
produc
either
secret
protein
inclus
bodi
howev
viral
parasit
antigen
extent
posttransl
modif
requir
retain
threedimension
structur
dictat
produc
eukaryot
needl
deliveri
addit
vector
use
induc
immun
ovo
rautenschlein
et
al
current
ovo
vaccin
gain
signific
popular
due
eas
handl
provid
immun
earli
life
poultri
addit
carri
gene
pathogen
vector
also
carri
immunomodulatori
gene
act
adjuv
enhanc
efficaci
vaccin
raggo
et
al
giavedoni
et
al
although
vector
vaccin
mani
advantag
consider
must
given
antigen
deliv
exampl
one
would
choos
viral
vector
immun
respons
carbohydr
lipopolysaccharid
lp
antigen
need
contrast
bacteri
vector
would
ideal
vaccin
similarli
one
would
choos
bacteri
vector
deliv
viral
protein
whose
confirm
sensit
posttransl
modif
thu
appropri
vector
import
antigen
deliv
vector
convent
kill
vaccin
produc
inactiv
infecti
agent
replic
host
without
alter
immunogen
protect
protein
thu
protein
infecti
agent
present
vaccin
nucleic
acid
damag
extent
agent
replic
unfortun
mani
inactiv
agent
impact
immunogen
damag
alter
specif
protein
therefor
import
achiev
balanc
full
inactiv
reduct
immunogen
ferguson
et
al
unfortun
infecti
agent
especi
may
aggreg
possibl
inactiv
agent
penetr
aggreg
result
outbreak
diseas
occur
due
improp
inactiv
brown
thu
continu
search
new
inactiv
agent
inactiv
vaccin
critic
protect
antigen
present
concentr
suffici
induc
immun
respons
bacteria
mani
virul
factor
may
extracellular
secret
protein
therefor
present
suffici
quantiti
whole
inactiv
organ
induc
protect
immun
possibl
best
exampl
rtx
toxin
mannheimia
actinobacillu
pasteurella
speci
shewen
wilki
antigen
critic
effect
vaccin
secret
therefor
present
whole
kill
inactiv
vaccin
overcom
problem
compani
spike
whole
kill
inactiv
vaccin
cultur
system
ensur
immunogen
although
often
expens
difficult
scaleup
requir
especi
viral
glycoprotein
sinc
viral
glycoprotein
gener
anchor
cell
membran
requir
destruct
cell
purifi
glycoprotein
overcom
impedi
possibl
remov
transmembran
anchor
allow
secret
protein
kowalski
et
al
increas
yield
also
reduc
purif
cost
therebi
make
vaccin
afford
livestock
applic
signific
advanc
product
subunit
vaccin
made
express
antigen
plant
confer
posttransl
event
present
mammalian
cell
advantag
possibl
target
vaccin
antigen
oil
bodi
plant
van
rooijen
moloney
make
vaccin
thermost
allow
eas
purif
importantli
vaccin
alreadi
incorpor
metaboliz
oil
adjuv
although
current
licens
vaccin
produc
plant
envisag
occur
shortli
number
compani
current
test
number
vaccin
newest
addit
armamentarium
vaccin
genet
vaccin
polynucleotid
vaccin
commonli
refer
dna
vaccin
concept
dna
vaccin
extrem
simpl
plasmid
express
gene
encod
antigen
interest
inject
anim
express
protein
vaccin
interest
thu
anim
act
bioreactor
produc
vaccin
consequ
anim
immun
simpl
process
requir
downstream
protein
purif
although
requir
plasmid
purif
abolish
need
adjuv
anoth
advantag
depend
rout
administr
vaccin
gener
induc
humor
cellular
immun
primarili
antigen
produc
endogen
posttransl
modif
similar
seen
follow
regular
viral
infect
furthermor
improv
enhanc
immun
well
drive
cellmedi
arm
immun
system
achiev
coadministr
dnabas
vaccin
plasmid
encod
hanlon
et
al
although
concept
simpl
actual
event
must
occur
make
dna
vaccin
possibl
mani
first
effici
transfect
low
thu
plasmid
actual
get
nucleu
express
antigen
overcom
problem
variou
method
use
increas
transfect
includ
electropor
formul
differ
polym
lipidbas
vesicl
mechan
deliveri
use
air
gene
gun
review
van
drunen
littelvan
den
hurk
et
al
second
case
rna
virus
bacteri
gene
often
necessari
introduc
intron
remov
cryptic
splice
site
ensur
express
occur
even
entri
plasmid
nucleu
alter
codon
bia
also
proven
case
enhanc
express
effect
made
enhanc
efficaci
dna
vaccin
livestock
review
number
occas
possibl
effici
method
deliveri
genet
vaccin
use
alphaviru
replicon
schultzcherri
et
al
sinc
alphavirus
natur
target
cell
infect
ideal
deliveri
vehicl
use
alphaviru
replicon
system
envelop
engin
way
effici
target
antigenpres
cell
dendrit
cell
activ
target
vaccin
sinc
replicon
abl
reproduc
deem
safe
although
still
mani
hurdl
overcom
make
dna
vaccin
routin
mani
speci
first
dnabas
vaccin
alreadi
licens
control
west
nile
viru
hors
regulatori
path
set
highli
like
other
licens
shortli
previous
agricultur
diseas
surveil
erad
program
larg
base
serolog
confirm
infect
destruct
quarantin
herd
limit
spread
diseas
due
relianc
serolog
confirm
countri
ban
vaccin
exot
diseas
possibl
best
exampl
approach
footandmouth
diseas
introduct
footandmouth
diseas
countri
normal
free
diseas
result
quarantin
slaughter
erad
diseas
rather
conduct
ring
vaccin
sinc
ring
vaccin
would
result
serolog
posit
anim
countri
would
continu
consid
infect
long
serolog
posit
anim
countri
howev
applic
serolog
test
differenti
vaccin
infect
anim
potenti
chang
practic
countri
move
erad
endem
diseas
control
novel
introduc
diseas
vaccin
program
industri
global
commun
thu
vaccin
accept
driven
econom
individu
produc
also
often
polit
motiv
trade
interest
macroeconom
issu
thu
countri
declar
diseasefre
countri
use
diseasefre
statu
effect
trade
barrier
keep
livestock
countri
diseasefre
confid
develop
diva
vaccin
diagnost
test
simpler
perform
hope
entir
globe
would
embrac
type
vaccin
reduc
accident
introduct
exot
diseas
countri
introduc
reduc
number
anim
needlessli
slaughter
return
countri
diseasefre
statu
regardless
type
vaccin
develop
formul
deliv
properli
full
benefit
vaccin
achiev
import
formul
deliv
dramat
influenc
qualiti
well
magnitud
immun
respons
gener
exampl
parenter
administ
nonrepl
vaccin
induc
system
immun
respons
littl
abil
induc
mucos
immun
current
extens
evid
suggest
deliv
vaccin
mucos
site
effect
way
induc
mucos
immun
anoth
advantag
mucos
deliveri
anim
also
develop
system
immun
addit
mucos
immun
addit
broaden
immun
respons
mucos
immun
advantag
avoid
pain
inject
site
reaction
broken
needl
etc
associ
parenter
inject
rout
administr
also
less
expens
depend
manag
system
may
difficult
perform
exampl
wild
rang
cattl
recept
intranas
deliveri
vaccin
therefor
oral
deliveri
may
attract
circumst
unfortun
despit
mani
experiment
report
oral
vaccin
licens
livestock
reason
lack
effect
deliveri
system
target
gutassoci
lymphoid
tissu
galt
difficulti
deliv
vaccin
galt
result
combin
mani
factor
includ
degrad
antigen
variou
physiolog
barrier
exampl
rumin
travers
rumen
intestin
galt
provid
major
challeng
howev
despit
challeng
number
promis
develop
pursu
critic
develop
robust
detect
system
differenti
vaccin
immun
anim
natur
infect
anim
might
carrier
diseas
aspir
led
develop
diva
vaccin
vaccin
lack
one
highli
immunogen
protein
still
contain
critic
protein
need
induc
protect
sinc
vaccin
lack
specif
protein
companion
diagnost
test
develop
serolog
differenti
infect
vaccin
anim
diva
although
diva
vaccinesdiagnost
test
use
convent
kill
vaccin
exampl
kill
fmd
vaccin
induc
antibodi
viral
nonstructur
protein
nsp
clavijo
et
al
trend
use
gene
delet
subunit
diva
vaccin
first
gene
delet
vaccin
use
erad
pseudorabi
viru
vaccin
result
natur
delet
glycoprotein
ge
gene
viru
van
oirschot
et
al
vaccin
use
decad
control
pseudorabi
viru
pig
known
barta
strain
coincident
also
ge
delet
could
use
marker
differenti
vaccin
anim
latent
carrier
diseas
result
first
diva
vaccin
mani
area
free
pseudorabi
viru
although
pseudorabi
viru
natur
occur
viru
avail
recombin
dna
technolog
combin
knowledg
gene
sequenc
abil
identifi
nonessenti
gene
mani
pathogen
delet
provid
us
great
opportun
develop
diva
vaccin
almost
infecti
diseas
result
initi
success
sever
marker
vaccin
alreadi
commerci
avail
role
contribut
diseas
erad
appear
promis
howev
diva
vaccin
embrac
industri
need
support
variou
level
govern
includ
livestock
industri
ensur
biopharmaci
industri
develop
vaccin
exampl
opportun
develop
diva
vaccin
footandmouth
diseas
intern
commun
yet
appear
will
embrac
vaccin
footandmouth
diseas
countri
normal
footandmouth
diseas
free
clavijo
et
al
case
footandmouth
diseas
diva
test
avail
base
detect
antibodi
nsp
prefer
diagnost
method
distinguish
viral
infect
carrier
anim
vaccin
anim
yet
embrac
intern
trade
commun
thu
even
though
better
technolog
avail
guarante
technolog
embrac
sinc
mani
virus
bacteria
surviv
gastrointestin
tract
use
vector
vaccin
develop
provid
oral
mucos
deliveri
possibl
best
exampl
vaccin
vacciniavector
rabi
vaccin
case
rabi
glycoprotein
insert
vaccinia
viru
incorpor
bait
control
rabi
viru
wildlif
brochier
et
al
brochier
et
al
advantag
approach
one
choos
thermost
vector
vaccin
remain
viabl
environ
signific
length
time
second
one
need
trap
individu
anim
sinc
routin
encount
bait
normal
activ
eat
bait
get
vaccin
brochier
et
al
similarli
enter
bacteria
salmonella
also
use
vector
carri
varieti
vaccin
antigen
although
safeti
issu
prior
releas
vector
environ
thoroughli
investig
alway
concern
possibl
unwarr
potenti
consequ
releas
recombin
agent
environ
overcom
concern
interest
develop
oral
deliveri
system
nonliv
antigen
possibl
encapsul
antigen
novel
polymer
microparticl
particl
produc
rang
polym
protect
antigen
degrad
gastrointestin
respiratori
tract
target
vaccin
tonsilar
crypt
cell
peyer
patch
gastrointestin
respiratori
tract
respect
microparticl
effect
must
engulf
cell
peyer
patch
signific
work
focus
investig
optim
size
particl
effect
uptak
uptak
also
modul
chang
charg
hydrophob
link
specif
ligand
particl
target
vaccin
cell
exampl
size
polylactidecoglycolid
plg
microparticl
studi
extens
regard
uptak
transport
lymph
node
one
could
gener
riski
particl
taken
easier
peyer
patch
particl
case
plg
algin
particl
eldridg
et
al
kim
et
al
current
interest
produc
nanoparticl
variou
drugdeliveri
system
also
exploit
vaccin
deliveri
shown
smaller
particl
better
larg
particl
uptak
thu
clear
size
import
effici
uptak
microparticl
carri
vaccin
antigen
furthermor
sinc
mucosa
neg
charg
positivecharg
particl
effect
uptak
negativecharg
particl
anoth
approach
enhanc
uptak
microparticl
link
variou
lectin
microparticl
specif
target
cell
pappo
et
al
manti
et
al
addit
abl
directli
target
microparticl
oral
mucosa
interest
also
increas
abl
use
microparticl
develop
singl
dose
vaccin
wherebi
microparticl
differ
composit
employ
particl
releas
antigen
immedi
upon
uptak
other
releas
antigen
week
uptak
cleland
et
al
tamber
et
al
approach
especi
attract
sinc
would
provid
prime
immun
system
upon
vaccin
booster
later
recent
demonstr
hiv
vaccin
baboon
cleland
et
al
enhanc
efficaci
microparticl
deliveri
vehicl
possibl
incorpor
adjuv
antigen
microparticl
deliv
antigen
also
provid
immun
system
boost
incorpor
saponinderiv
adjuv
cpg
odn
microparticl
shown
enhanc
immun
respons
antigen
incorpor
microparticl
hunter
et
al
diwan
et
al
although
plg
microparticl
extens
studi
oral
deliveri
microparticl
system
numer
microparticl
also
investig
includ
polycapralacton
pec
starchbas
microparticl
algin
microparticl
recent
polyphosphazen
payn
et
al
benoit
et
al
mcneal
et
al
wikingsson
sjoholm
rydel
sjoholm
reason
investig
formul
gener
plg
microparticl
gener
requir
organ
solvent
upon
degrad
intracellular
environ
gener
acid
environ
case
detriment
preserv
differ
epitop
possibl
reason
incorpor
brucella
ovi
pec
microparticl
much
effect
protect
anim
challeng
live
b
ovi
versu
encapsul
antigen
plg
confer
protect
murillo
et
al
also
interest
note
qualiti
immun
respons
induc
pec
microparticl
associ
respons
wherea
induc
plg
encapsul
antigen
associ
immun
respons
signific
studi
also
conduct
algin
microparticl
variou
anim
speci
includ
cattl
rabbit
chicken
bowersock
et
al
case
oral
deliveri
vaccin
enhanc
antigen
encapsul
algin
particl
enhanc
detect
microparticl
also
contain
adjuv
due
mild
natur
action
licens
adjuv
possess
requir
featur
ideal
adjuv
therefor
quest
continu
better
adjuv
induc
balanc
immun
respons
also
safe
induc
inject
site
reaction
sinc
mani
adjuv
attract
cell
immun
system
site
inject
one
requir
fine
balanc
attract
appropri
cell
requir
induct
immun
caus
overstimul
result
unwarr
inject
site
reaction
inde
estim
cattl
inject
site
reaction
cost
approxim
site
result
need
trim
van
donkersgo
et
al
reason
inject
given
subcutan
neck
meat
cut
less
qualiti
case
cat
aluminum
adjuv
implic
fibrosarcoma
burton
mason
therefor
trend
move
nonadjuv
vaccin
cat
major
problem
adjuv
gener
induc
strong
immun
respons
littl
immun
respons
concern
quest
continu
novel
adjuv
caus
advers
reaction
still
induc
desir
respons
current
often
use
adjuv
includ
aluminum
salt
adher
antigen
surfac
act
depot
antigen
present
antigenpres
cell
infiltr
inject
site
sinc
antigen
need
absorb
aluminum
salt
surpris
antigen
absorb
effici
requir
precis
ph
absorpt
claesson
et
al
anoth
disadvantag
aluminum
salt
gener
induc
respons
littl
cellmedi
immun
respons
oil
emuls
anoth
commonli
use
famili
adjuv
veterinari
vaccin
oil
emuls
vari
miner
plant
oil
oil
water
water
oil
emuls
major
problem
miner
oil
nonmetaboliz
lead
residu
inject
site
reaction
overcom
problem
metaboliz
oil
replac
miner
oil
mani
metaboliz
oil
plantbas
addit
use
plantderiv
oil
plant
compon
immunomodulatori
properti
also
use
either
combin
oil
alon
kensil
et
al
wu
et
al
possibl
best
known
plantderiv
adjuv
saponin
quil
variou
fraction
quil
best
known
one
mechan
action
abil
stimul
cytokin
help
creat
environ
requir
drive
immun
respons
enhanc
activ
produc
algin
microparticl
also
possibl
encapsul
live
microorgan
therebi
protect
transit
stomach
gastrointestin
tract
clearli
demonstr
abil
encapsul
bovin
adenoviru
algin
microspher
develop
immun
respons
follow
oral
administr
viru
mittal
et
al
recent
class
synthet
biodegrad
polym
vaccin
deliveri
well
act
adjuv
polyphosphazen
numer
report
document
polyphosphazen
perform
better
convent
adjuv
incorpor
vaccin
payn
andrianov
furthermor
possibl
formul
polyphosphazen
microparticl
organ
solvent
thu
procedur
extrem
mild
one
captur
benefit
microencapsul
well
adjuvant
one
type
particl
although
polyphosphazen
microparticl
proven
effect
preliminari
studi
mice
requir
investig
applic
livestock
companion
anim
although
identifi
area
current
interest
research
microencapsul
deliveri
vaccin
microparticl
must
emphas
studi
larg
anim
demonstr
applic
microparticl
formul
antigen
oral
immun
clearli
much
work
requir
larg
anim
knowledg
gain
regard
need
stimul
galt
size
microparticl
charg
enhanc
immun
respons
combin
preliminari
studi
number
veterinari
speci
demonstr
potenti
util
encourag
need
continu
pursu
due
rather
poor
immunogen
inactiv
subunit
vaccin
almost
alway
requir
combin
vaccin
antigen
adjuv
effect
current
adjuv
classifi
miner
salt
synthet
adjuv
oil
emuls
plant
product
lipidbas
vehicl
bacteri
product
final
molecular
adjuv
cytokin
combin
cox
coulter
human
aluminum
salt
licens
wherea
veterinari
medicin
mani
differ
adjuv
current
use
unfortun
exact
mechan
adjuv
work
fulli
understood
differ
adjuv
probabl
differ
mechan
action
rang
creat
depot
antigen
attract
antigenpres
cell
site
vaccin
creat
cytokin
environ
vaccin
site
help
expand
immun
reactiv
cell
regardless
mechan
possibl
combin
lipid
compon
form
iscom
cagelik
structur
contain
antigen
interest
cox
et
al
morein
et
al
thu
iscom
act
deliveri
vehicl
enhanc
immun
antigen
incorpor
iscom
current
iscombas
vaccin
incorpor
viral
glycoprotein
iscom
vaccin
deliv
either
parenter
mucos
induc
antibodi
cellular
respons
takahashi
et
al
morein
et
al
one
disadvantag
iscom
poor
load
capac
difficulti
incorpor
nonmembran
antigen
iscom
reid
similar
iscom
liposom
use
experiment
excel
result
addit
use
subunit
vaccin
lipidbas
deliveri
system
also
effici
deliveri
dnabas
vaccin
zelphati
szoka
earli
vaccin
contain
whole
kill
bacteria
demonstr
vaccin
induc
signific
reaction
led
suggest
mani
compon
could
good
adjuv
inde
proven
correct
assumpt
mani
bacteri
product
whether
lp
variou
toxin
cholera
toxin
escherichia
coli
lt
etc
bacteri
dna
gener
induc
cell
signal
primarili
tolllik
receptor
tlr
product
cytokin
chemokin
activ
excess
stimul
lead
advers
reaction
overcom
excess
reaction
less
toxic
analog
bacteri
compon
develop
ulrich
myer
one
least
reactogen
bacteri
compon
current
show
signific
promis
adjuv
cpg
krieg
et
al
specif
synthet
oligonucleotid
sequenc
signal
receptor
signific
work
last
decad
identifi
specif
cpg
motif
stimul
immun
respons
weeratna
et
al
furthermor
activ
recombin
convent
vaccin
ioannou
et
al
addit
activ
follow
ovo
deliveri
gomi
et
al
sinc
mani
adjuv
act
abil
induc
cytokin
inject
site
sinc
cytokin
critic
induct
immun
numer
investig
attempt
incorpor
cytokin
vaccin
formul
limit
success
heath
greatest
concern
cytokin
adjuv
difficulti
maintain
current
concentr
cytokin
drive
immun
respons
without
overstimul
toxic
consequ
recent
report
use
kill
pseudomona
bacteria
contain
interferon
gamma
adjuv
demonstr
excel
adjuvant
advers
effect
gaertner
et
al
thu
high
probabl
eventu
use
molecul
adjuv
use
vaccin
anim
health
restrict
protect
morbid
mortal
host
regularli
employ
key
element
public
health
program
among
first
wide
success
appli
applic
vaccin
anim
health
rabi
principl
zoonot
diseas
varieti
domest
wildlif
host
see
chapter
classic
inactiv
rabi
vaccin
use
control
devast
diseas
domest
anim
wildlif
target
address
attenu
live
approach
recent
success
recombin
vector
vaccin
perhap
even
profound
potenti
impact
public
health
control
avian
influenza
use
convent
recombin
vaccin
demonstr
significantli
decreas
spread
viru
within
infect
flock
therebi
reduc
spread
viru
vertic
human
popul
zoonot
diseas
vaccin
real
potenti
impact
incid
human
popul
brucellosi
rumin
nipah
viru
norwalk
agent
swine
focu
diseas
exposur
zoonot
typic
food
chain
vaccin
carri
special
issu
agent
may
alway
princip
diseas
host
rather
commens
part
host
natur
flora
campylobact
poultri
e
coli
typic
exampl
diseas
agent
resid
part
host
normal
flora
becom
concern
human
expos
contamin
food
safeti
water
food
suppli
clearli
led
greatest
improv
public
safeti
last
centuri
half
statist
british
home
offic
indic
per
popul
uk
die
annual
foodrel
ill
improv
along
food
chain
reduc
number
approxim
per
remain
constant
sinc
move
anim
diseas
vaccin
use
control
must
note
vaccin
use
food
produc
anim
must
detect
singl
sampl
port
entri
entir
shipment
subject
reject
major
expens
processor
one
rel
new
technolog
hold
promis
address
broken
needl
issu
well
inject
site
meat
qualiti
issu
administr
vaccin
via
needlefre
devic
sever
compani
produc
distribut
needlefre
devic
administr
vaccin
swine
cattl
devic
either
util
exist
vaccin
formul
prefer
util
formul
specif
design
take
advantag
needlefre
rout
administr
one
advantag
exploit
needlefre
technolog
abil
target
effici
popul
antigenpres
cell
plasmacytoid
dendrit
cell
concentr
dermi
cell
typic
bypass
needl
inject
target
dendrit
cell
potenti
reduc
antigen
quantiti
reduc
elimin
need
adjuv
significantli
reduc
volum
inject
factor
address
inject
site
meat
qualiti
broken
needl
issu
vaccin
technolog
emerg
recent
year
includ
use
recombin
viru
vector
nucleic
acid
base
vaccin
technolog
offer
sever
potenti
advantag
allow
use
vaccin
allow
differenti
infect
vaccin
antigen
exposur
critic
diseas
control
situat
particularli
deal
introduct
exot
diseas
agent
instanc
recombin
vaccin
achiev
better
immunolog
respons
obtain
nativ
antigen
use
adjuv
may
reduc
elimin
nucleic
acid
vaccin
offer
major
advantag
regard
puriti
vaccin
elimin
adjuv
abil
overcom
interfer
matern
antibodi
young
anim
opportun
prime
immun
system
subsequ
boost
recombin
nativ
antigen
formul
prevent
control
infecti
diseas
food
anim
continu
issu
face
farmer
produc
agent
endem
respect
speci
other
highli
contagi
requir
fast
diagnosi
rapid
respons
achiev
control
absenc
vaccin
aspect
food
anim
vaccin
come
forefront
recent
year
potenti
exot
agent
enter
unit
state
either
natur
incident
rout
via
intent
terrorist
introduct
domest
herd
flock
one
exampl
threat
influenza
viru
close
proxim
peopl
swine
poultri
southeast
asia
countri
continu
provid
neg
affect
qualiti
food
unit
state
product
anim
typic
includ
beef
pork
poultri
minor
input
sheep
goat
industri
advent
modern
vaccin
technolog
provid
tremend
benefit
largescal
product
capabl
speci
result
posit
econom
impact
regard
cost
product
primari
produc
cost
product
consum
use
vaccin
product
anim
medicin
translat
one
aspect
overal
product
scenario
concept
herd
health
manag
herd
health
manag
concept
transcend
prevent
diseas
anim
hous
environ
nutrit
manag
issu
contribut
low
cost
bounti
high
qualiti
food
suppli
nation
enjoy
mani
decad
issu
routin
face
produc
regard
applic
vaccin
technolog
product
anim
includ
effici
mass
vaccin
impact
food
qualiti
due
local
reaction
vaccin
site
rare
seriou
issu
broken
needl
site
inject
applic
mass
vaccin
technolog
success
commerci
poultri
industri
product
typic
administ
aerosol
exposur
via
drink
water
system
technolog
difficult
appli
swine
beef
primarili
design
product
facil
formul
current
requir
achiev
effect
vaccin
respons
issu
inject
site
reaction
primarili
associ
swine
beef
product
vaccin
still
administ
tradit
syring
needl
approach
issu
address
target
specif
low
meat
valu
site
inject
particularli
later
neck
region
preserv
integr
valu
high
qualiti
meat
cut
associ
leg
loin
region
addit
vaccin
formul
improv
better
select
less
reactiv
adjuv
lower
dose
volum
target
efficaci
subcutan
inject
instead
requir
intramuscular
deposit
antigen
issu
broken
needl
difficult
address
potenti
break
alway
exist
herd
vaccin
procedur
though
rare
discoveri
needl
meat
product
typic
make
headlin
result
damag
reput
market
potenti
processor
export
custom
specif
japan
market
set
zero
toler
broken
needl
result
use
metal
detector
screen
meat
shipment
posit
signal
opportun
coinfect
host
multipl
influenza
virus
potenti
reassort
viru
genom
emerg
strain
highli
virul
livestock
human
popul
alway
exist
vaccin
lead
defens
threat
among
success
broadli
appli
commerci
vaccin
use
anim
health
target
poultri
industri
entir
rang
viral
bacteri
vaccin
appli
throughout
cours
product
allow
diseas
newcastl
viru
marek
diseas
would
normal
decim
flock
strictli
control
vaccin
may
appli
drink
water
poultri
hous
aerosol
spray
cabinet
hatcheri
recent
mass
administr
ovo
devic
poultri
also
find
consist
appli
program
food
safeti
vaccin
anim
health
accord
foodnet
bacteri
pathogen
highest
rel
incid
caus
bacteri
foodborn
ill
human
period
campylobact
salmonella
shigella
anonym
campylobact
salmonella
infect
acquir
handl
consumpt
contamin
poultri
product
although
differ
serotyp
salmonella
exist
salmonella
enterica
subspeci
enterica
enterid
oranienburg
montevideo
newport
typhimurium
anatum
derbi
bredeney
respons
gastrointestin
diseas
human
group
paratyphoid
pt
salmonella
enterid
typhimurium
montevideo
frequent
isol
poultri
usual
acut
selflimit
gastrointestin
ill
character
diarrhea
fever
abdomin
cramp
common
present
campylobact
salmonella
infect
human
poultri
infect
salmonella
present
minim
clinic
sign
clinic
sign
attribut
campylobact
chicken
age
salmonella
campylobact
colon
chicken
intestin
tract
larg
number
bacteria
shed
fece
intestin
contamin
main
sourc
contamin
process
plant
campylobact
colon
detect
level
occur
approxim
week
age
establish
flock
spread
rapidli
horizont
transmiss
chicken
well
document
recent
report
suggest
vertic
transmiss
may
play
role
spread
salmonella
campylobact
poultri
flock
well
gast
shane
stern
preharvest
harvest
postharvest
measur
use
effort
reduc
salmonella
campylobact
incid
poultri
preharvest
measur
includ
use
feed
addit
antibiot
prebiot
probiot
synbiot
shortchain
organ
acid
competit
exclus
vaccin
sever
vaccin
avail
typhimurium
enterid
wherea
vaccin
campylobact
chicken
salmonella
infect
known
elicit
strong
humor
respons
chicken
wherea
littl
known
cellular
immun
respons
howev
wide
accept
cellmedi
immun
play
import
role
humor
immun
tissu
clearanc
virul
strain
mucos
antibodi
respons
promyeolcyt
seem
import
intestin
clearanc
gast
inde
recent
studi
indic
oral
inocul
chicken
salmonella
typhimurium
result
earli
express
chemokin
spleen
liver
follow
increas
express
gamma
interferon
increas
number
cell
withanag
et
al
respons
correl
respons
system
infect
speci
respons
st
infect
gut
clear
one
studi
increas
proinflammatori
cytokin
express
anoth
substanti
increas
cytokin
respons
gast
withanag
et
al
vaccin
wide
use
control
salmonella
infect
poultri
live
inactiv
vaccin
util
though
former
shown
induc
stronger
longlast
immun
respons
gast
van
immerseel
et
al
howev
neither
vaccin
type
induc
complet
protect
colon
intestin
therefor
control
program
remain
integr
approach
vaccin
proper
prevent
measur
process
plant
handl
transport
chain
final
end
consum
current
vaccin
avail
control
campylobact
chicken
though
sever
experiment
approach
shown
induc
humor
immun
respons
degre
protect
challeng
stern
et
al
cawthraw
et
al
khouri
meinersmann
noor
et
al
widder
et
al
widder
et
al
rice
et
al
shane
stern
howev
evid
complet
protect
intestin
colon
studi
stern
et
al
cawthraw
et
al
khouri
meinersmann
noor
et
al
widder
et
al
widder
et
al
rice
et
al
one
import
day
anonym
complic
affect
mostli
children
elderli
infect
go
acut
renal
failur
hemolyt
urem
syndrom
may
lead
death
overal
death
rate
longterm
complic
e
coli
anim
reservoir
primari
host
rumin
specif
cattl
great
major
case
link
back
handl
consumpt
contamin
meat
plant
veget
water
direct
contamin
farm
set
pet
zoo
respons
signific
number
case
incid
unit
state
estim
case
per
annum
includ
death
anonym
anonym
strain
highli
pathogen
littl
bacteria
capabl
caus
infect
make
infect
e
coli
one
frequent
report
sever
foodborn
ill
develop
countri
human
diseas
etiolog
manag
review
recent
genu
speci
e
coli
import
pathogen
anim
speci
caus
mainli
enter
diseas
neonat
diarrhea
caus
enterotoxinogen
e
coli
etec
calv
piglet
e
coli
pathogen
cattl
bacterium
colon
intestin
rumin
effici
caus
nonsymptomat
infect
bacterium
shed
often
intermitt
high
number
fece
fecal
contamin
meat
pack
plant
bed
water
fruit
veget
farm
lead
human
exposur
asymptomat
infect
widespread
mani
herd
across
countri
within
herd
individu
rate
highli
heterogen
less
major
anim
shed
environ
importantli
particular
anim
shed
high
level
matthew
et
al
genu
speci
e
coli
divers
group
compris
approxim
antigen
serotyp
eg
antigen
carri
polysaccharid
side
chain
lp
compon
bacteri
outer
membran
signific
variat
also
note
chromosom
level
anonym
importantli
e
coli
purpos
discuss
character
virul
factor
attach
e
coli
part
group
strain
call
enteropathogen
e
coli
epec
attach
enterocyt
caus
lesion
character
effac
destroy
cytoskeleton
attachingeffac
e
coli
molecular
mechan
well
describ
necessit
least
four
major
protein
esp
esp
b
tir
intimin
intimin
bacteri
outer
membran
protein
receptor
aspect
campylobact
colon
campylobact
usual
detect
chicken
less
week
age
commerci
broiler
product
condit
jacobsreitsma
et
al
evan
sayer
howev
experiment
shown
chicken
less
week
age
suscept
campylobact
infect
result
colon
gut
suggest
genet
factor
agerel
resist
infect
hald
et
al
shane
stern
observ
agerel
resist
colon
campylobact
recent
attribut
presenc
high
level
matern
antibodi
sahin
et
al
declin
matern
antibodi
associ
increas
colon
rate
addit
matern
antibodi
shown
opson
campylobact
vitro
experi
howev
well
document
chicken
matern
antibodi
infect
colon
campylobact
higher
dose
challeng
inoculum
use
noor
et
al
hald
et
al
immun
intervent
nondiseas
caus
gut
colon
bacteria
inde
challeng
one
consid
access
specif
immun
compon
gut
content
bacteria
locat
immedi
exclud
activ
immun
cell
content
though
may
activ
submucos
level
although
solublespecif
compon
immunoglobulin
plausibl
access
bacteria
activ
absenc
compon
complement
phagocyt
cell
may
suffici
kill
elimin
bacteria
gut
one
option
prevent
colon
first
place
use
immun
intervent
order
accomplish
better
understand
factor
lead
colon
may
provid
venu
explor
vaccin
develop
e
coli
ubiquit
pathogen
human
anim
respons
wide
rang
diseas
includ
enter
septicem
urinari
track
infect
recent
year
signific
increas
bloodi
diarrhea
hemorrhag
coliti
caus
particular
strain
e
coli
e
coli
observ
industri
countri
especi
unit
state
made
headlin
hemolyt
urem
syndrom
caus
death
often
cluster
consumpt
undercook
ground
meat
often
refer
hamburg
diseas
diseas
manifest
common
form
sever
bloodi
diarrhea
accompani
abdomin
cramp
littl
fever
may
resolv
tir
attach
molecul
virul
factor
describ
complex
process
deng
et
al
import
find
understand
diseas
transmiss
epidemiolog
vaccin
studi
descript
preferenti
adhes
site
rectum
cattl
naylor
et
al
attach
key
compon
colon
cattl
first
step
diseas
human
toxin
toxic
manifest
diseas
caus
secret
two
toxin
call
shiga
toxin
gene
toxin
carri
bacteriophag
toxin
also
call
verocytotoxin
e
coli
secret
verotoxigen
e
coli
stec
vtec
implic
apparit
hemolyt
urem
syndrom
human
karch
et
al
resist
cattl
effect
toxin
provid
explan
absenc
diseas
manifest
anim
mani
approach
suggest
develop
vaccin
use
mani
newer
technolog
well
tradit
approach
target
vaccin
cattl
reduct
elimin
infect
excret
diseas
prevent
symptom
particularli
difficult
target
must
reach
colon
site
mucos
surfac
elimin
prevent
colon
bacteria
develop
exquisit
solut
parasit
ecolog
nich
advanc
approach
base
use
e
coli
secret
antigen
contain
sever
protein
involv
attach
eg
esp
tir
approach
use
tradit
technolog
built
precis
understand
pathogen
mechan
administ
three
time
subcutan
rout
led
signific
decreas
shed
level
challeng
model
field
trial
recent
test
howev
perform
field
condit
vaccin
fail
induc
reduct
preval
infect
van
donkersgo
et
al
plant
tobacco
cell
produc
intimin
caus
decreas
durat
shed
vaccin
administ
parenter
follow
booster
oral
rout
judg
et
al
antibodi
intimin
passiv
administ
piglet
provid
signific
protect
challeng
deannystrom
et
al
live
modifi
strain
e
coli
contain
truncat
intimin
molecul
also
provid
protect
clinic
diseas
ae
e
coli
model
rabbit
agin
et
al
final
genet
modifi
toxoid
shiga
toxin
provid
neutral
antibodi
protect
toxin
challeng
homolog
fashion
lead
conclus
cross
protect
wen
et
al
also
note
sever
nonvaccin
approach
also
propos
reduc
infect
farm
level
includ
nutrit
probiot
princip
challeng
twofold
first
increas
intrins
efficaci
vaccin
protocol
optim
formul
administr
regim
second
demonstr
overal
effici
farm
intervent
strategi
includ
infect
reduc
risk
human
yet
demonstr
mani
reason
believ
reduct
sourc
would
provid
signific
benefit
matthew
et
al
consid
highli
sporad
well
foodborn
natur
diseas
littl
interest
develop
vaccin
human
human
especi
light
increas
level
antibiot
resist
observ
strain
improv
treatment
tool
avail
includ
immunolog
tool
prioriti
mani
streptococc
infect
describ
human
infect
sui
rare
zoonot
diseas
usual
involv
specif
risk
group
consist
individu
close
occup
contact
infect
swine
farmer
slaughterhous
worker
hunter
feral
swine
recent
rare
occurr
larg
cluster
patient
high
level
mortal
observ
china
huang
et
al
normil
small
number
patient
expos
infecti
meat
oppos
anim
carcass
investig
point
new
variant
bacteria
thu
human
diseas
caus
sui
remain
rel
rare
sever
zoonot
diseas
properli
speak
foodborn
infect
oppos
e
coli
salmonella
listeria
clinic
manifest
frequent
mening
case
sepsi
divers
manifest
includ
endocard
may
observ
deaf
common
longterm
complic
streptococc
mening
macinn
desrosi
death
occur
diseas
rare
fatal
sui
infect
anim
widespread
pig
popul
across
world
frequent
colon
upper
respiratori
tract
swine
without
caus
diseas
howev
induc
diseas
either
primari
pathogen
perhap
increas
virul
certain
strain
becom
pathogen
secondarili
anoth
factor
stress
immunodepress
concurr
infect
eg
viral
infect
diseas
manifest
mani
differ
form
death
fever
lame
septicemia
endocard
martinez
et
al
strain
regularli
maintain
efficaci
sui
induc
diseas
remain
signific
costli
diseas
swine
industri
addit
respons
infrequ
sever
potenti
deadli
zoonosi
human
lack
detail
understand
virul
preclud
develop
efficaci
modern
vaccin
cryptosporidiosi
diseas
human
livestock
companion
anim
wildlif
bird
reptil
fish
infect
one
speci
protozoan
parasit
cryptosporidium
clinic
outcom
diseas
vari
greatli
speci
speci
also
depend
virul
factor
parasit
host
immun
respons
immunocompet
human
infect
asymptomat
even
though
parasit
replic
excret
ill
develop
outcom
rang
mild
enter
symptom
without
diarrhea
profus
wateri
diarrhea
addit
symptom
includ
abdomin
cramp
vomit
lowgrad
fever
fatigu
anorexia
ungar
mac
kenzi
et
al
diseas
self
limit
typic
resolv
within
week
organ
usual
infect
lower
small
intestin
immunosuppress
patient
extend
esophagu
throughout
intestin
tract
rectum
case
appendix
gall
bladder
bile
duct
pancrea
occasion
even
respiratori
tract
infect
ungar
human
frequent
found
organ
design
cryptosporidium
parvum
genotyp
human
genotyp
appear
hostspecif
infect
spread
among
human
organ
recogn
separ
speci
cryptosporidium
homini
morganryan
et
al
anoth
organ
design
c
parvum
genotyp
cattl
genotyp
zoonot
capabl
infect
spread
among
mani
mammalian
host
main
reservoir
c
parvum
genotyp
cattl
virtual
cattl
expos
parasit
first
month
life
calv
shed
larg
number
oocyst
g
fece
approxim
day
activ
immun
respons
develop
control
infect
howev
evid
suggest
infect
anim
carri
c
parvum
life
shed
oocyst
intermitt
collect
data
suggest
vast
number
oocyst
pass
environ
cattl
contribut
significantli
larg
number
zoonot
transmiss
may
import
case
direct
exposur
cattl
fece
farm
undevelop
countri
waterborn
outbreak
develop
countri
diseas
occur
primarili
swine
enter
fatten
barn
beyond
week
age
diseas
signific
impact
econom
perform
herd
agent
sui
gramposit
cocci
part
broad
genu
streptococcu
import
featur
organ
signific
divers
serotyp
level
differ
capsular
type
describ
serotyp
common
isol
frequenc
vari
significantli
countri
countri
north
america
europ
serotyp
next
frequent
isol
martinez
et
al
genet
level
signific
divers
observ
herd
even
within
herd
interestingli
pathogen
strain
emerg
within
herd
seem
separ
distinctli
isol
obtain
healthi
swine
berthelotherault
et
al
molecular
level
differ
also
observ
express
put
virul
factor
smith
et
al
despit
best
effort
understand
exact
mechan
pathogen
virul
strain
well
abil
predict
virul
isol
strain
base
molecular
model
remain
elus
variou
protein
muramidasereleas
protein
mrp
extracellular
protein
factor
epf
hemolysin
suilysin
suggest
martinez
et
al
mutant
lack
gene
demonstr
attenu
de
greeff
et
al
suggest
simultan
presenc
three
factor
could
make
strain
virul
recent
addit
protein
propos
virul
factor
fibronectinbind
protein
gruen
et
al
arginin
deiminas
system
ad
okwumabua
chinnapapakkagari
kda
protein
unknown
function
found
reactiv
serum
infect
anim
demonstr
protect
llull
et
al
capsular
polysaccharid
sui
streptococci
may
also
play
import
role
busqu
et
al
follow
molecular
basi
virul
remain
unknown
antigen
variat
exist
within
put
virul
molecul
identifi
vaccin
diseas
abl
use
modern
technolog
recombin
express
requir
defin
antigen
essenti
two
type
vaccin
made
avail
live
attenu
strain
wisselink
et
al
haesebrouck
et
al
inactiv
whole
cell
bacterin
neither
met
signific
success
major
market
remain
occupi
autogen
bacterin
autogen
bacterin
could
provid
mean
avoid
signific
antigen
variat
strain
provid
vaccin
deriv
particular
strain
infect
herd
consid
variabl
strain
within
herd
one
expect
chang
immunocompromis
individu
frequent
observ
cattl
genotyp
cryptosporidium
pieniazek
et
al
morgan
et
al
unit
state
australia
case
appear
human
origin
food
waterborn
outbreak
human
genotyp
bovin
genotyp
organ
howev
europ
bovin
genotyp
respons
infect
human
genotyp
mclauchlin
et
al
alv
et
al
guyot
et
al
unit
kingdom
zoonot
transmiss
consid
major
rout
infect
human
hunter
et
al
sole
mechan
transmiss
oocyst
evolv
dispers
surviv
harsh
environ
long
period
time
oocyst
unusu
resist
natur
stress
mani
manmad
disinfect
control
infect
anim
popul
current
best
strategi
move
anim
clean
area
human
popul
disinfect
procedur
use
infect
cryptosporidium
initi
ingest
inhal
oocyst
measur
prevent
limit
spread
infect
must
target
elimin
reduc
oocyst
environ
despit
fact
drug
test
activ
c
parvum
vitro
vivo
still
effect
treatment
rehg
fayer
fetter
wood
et
al
armson
et
al
cattl
vaccin
c
parvum
might
reduc
environment
contamin
consequ
frequenc
waterborn
cryptosporidiosi
outbreak
human
sinc
cattl
may
expos
c
parvum
day
birth
immun
system
matur
activ
vaccin
like
mediat
signific
protect
thu
vaccin
c
parvum
attempt
purpos
gener
hyperimmun
colostrumcontain
antibodi
may
effect
passiv
immunotherapi
cryptosporidiosi
calv
calv
fed
hyperimmun
colostrum
prepar
oocyst
challeng
significantli
reduc
patent
period
oocyst
shed
day
diarrhea
compar
calv
fed
normal
colostrum
fayer
fetter
number
recombin
c
parvum
surfac
intern
antigen
express
dnaclon
technolog
immun
colostrum
specif
sever
recombin
c
parvum
protein
demonstr
efficaci
murin
rumin
model
cryptosporidiosi
promis
candid
protein
vaccin
develop
surfac
micronem
protein
sporozoit
detect
western
blot
analys
cryptosporidium
protein
use
fecal
antibodi
serum
cryptosporidiuminfect
human
anim
lumb
et
al
mead
et
al
hill
et
al
reper
et
al
defin
monoclon
antibodi
mab
iga
mab
provid
protect
infect
administ
oral
suckl
mice
tilley
et
al
comparison
two
recombin
form
one
produc
prokaryot
express
system
eukaryot
express
system
indic
potent
immun
respons
obtain
use
eukaryot
form
possibl
due
posttransl
modif
sagodira
et
al
report
preparturi
cow
immun
dna
encod
mammari
gland
produc
sporozoitespecif
antibodi
colostrum
jenkin
et
al
immun
colostrum
induc
reduct
c
parvum
develop
mice
defin
mab
mead
et
al
perryman
et
al
iga
enriquez
rigg
mab
reactiv
shown
signific
anticryptosporidi
activ
mice
perryman
et
al
report
late
gestat
holstein
cow
immun
immunodomin
epitop
develop
specif
antibodi
calv
receiv
immun
colostrum
significantli
protect
diarrhea
shed
significantli
fewer
oocyst
control
calv
antibodi
direct
shown
inhibit
sporozoit
vitro
suggest
direct
role
molecul
host
parasit
interact
barn
et
al
report
involv
homolog
substratedepend
locomot
sporozoit
sultan
et
al
well
host
cell
attach
invas
muller
et
al
suggest
consid
promis
vaccin
candid
cryptosporidiosi
summari
use
vaccin
public
health
tool
control
foodborn
ill
complex
import
field
reduc
bio
burden
food
produc
speci
target
speci
normal
carri
shed
alreadi
low
rate
human
pathogen
part
anim
normal
host
flora
signific
challeng
current
vaccin
technolog
case
develop
market
place
threat
foodborn
ill
alreadi
impress
low
level
though
public
expect
drop
still
therefor
must
understood
success
control
program
must
compon
fulli
integr
program
includ
husbandri
meat
process
handl
retail
custom
level
pathogen
present
vaccin
popul
circumst
especi
econom
pressur
exist
may
tendenc
decreas
use
vaccin
disastr
result
third
vaccin
protect
may
prevent
infect
becom
establish
mani
peopl
think
vaccin
claim
rare
found
product
label
unit
state
depart
agricultur
usda
regul
vaccin
us
requir
claim
grant
vaccin
must
demonstr
abl
prevent
colon
replic
challeng
organ
vaccin
challeng
anim
must
support
high
degre
confid
convinc
data
dehaven
usda
recogn
vari
level
protect
way
allow
label
claim
three
categori
often
written
label
aid
diseas
control
prevent
diseas
prevent
infect
vaccin
manufactur
gener
great
deal
data
independ
review
govern
agenc
becom
basi
label
claim
expect
vaccin
someth
unrealist
given
data
label
indic
perhap
greatest
caus
report
vaccin
failur
paraphras
old
adag
doubt
alway
read
label
topic
level
protect
note
vaccin
provid
efficaci
protect
may
come
direct
indirect
effect
direct
effect
reli
upon
provid
individu
immun
anim
receiv
protect
dose
vaccin
benefit
directli
addit
may
indirect
protect
herd
immun
result
vaccin
suffici
number
anim
given
popul
herd
immun
protect
nonvaccin
anim
within
popul
whether
flock
herd
group
result
reduct
abil
diseas
transmit
vaccin
individu
immun
occur
vaccin
capabl
reduc
shed
diseas
caus
agent
follow
infect
vaccin
anim
challeng
develop
optim
vaccin
program
deal
great
divers
exist
within
anim
world
probabl
singl
optim
program
occas
multitud
factor
need
consid
choos
vaccin
program
complex
speciesbre
differ
within
genet
select
occur
resist
select
diseas
divers
husbandri
practic
employ
date
back
centuri
mandat
govern
dispar
last
decad
tremend
advanc
understand
immun
system
major
domest
anim
speci
nonetheless
still
lag
behind
depth
knowledg
exist
immun
system
mice
men
stop
success
vaccin
program
develop
much
vaccinolog
practic
veterinari
medicin
anim
health
industri
gener
empir
driven
realiti
exist
rais
product
anim
work
veterinari
practic
make
live
depend
keep
anim
healthi
industri
vaccin
like
insur
polici
protect
event
one
hope
never
happen
tenth
penni
make
break
econom
busi
use
optim
vaccin
shown
prevent
diseas
reduc
need
pharmaceut
intervent
eg
reduc
antibiot
usag
improv
health
welfar
anim
knott
et
al
mcilroy
et
al
definit
protect
percept
vaccin
provid
steril
immun
diseas
agent
establish
infect
wide
held
gener
unfound
larg
unrealist
debat
immun
even
anim
best
interest
exposur
transient
infect
pathogen
help
keep
immun
respons
activ
vaccin
usual
provid
protect
one
three
level
first
lowest
level
protect
simpli
reduct
clinic
sign
associ
infect
reduct
may
decreas
diseas
sever
andor
durat
simpli
delay
onset
diseas
infect
still
becom
establish
case
anim
contagi
incontact
anim
although
may
reduct
level
shed
infecti
agent
immun
usual
capabl
stop
outbreak
progress
second
vaccin
may
induc
immun
prevent
clinic
sign
associ
infect
anim
show
overt
sign
infect
level
protect
may
actual
associ
reduct
shed
challeng
organ
reduc
spread
diseas
outbreak
unfortun
gener
rule
reli
upon
regard
reduct
shed
tend
specif
strain
involv
vaccin
infect
must
recogn
vaccin
protect
prevent
clinic
sign
diseas
identifi
lead
fals
assumpt
preval
diseas
result
adopt
tailor
vaccin
program
program
gener
design
consid
risk
eg
diseas
preval
exposur
likelihood
husbandri
eg
animaltoanim
contact
nutrit
environment
factor
eg
wildlif
vector
weather
cours
anim
eg
age
previou
diseas
experi
condit
influenc
tailor
vaccin
program
chang
rapidli
life
anim
inde
time
period
protect
requir
vari
greatli
chicken
unless
breed
anim
normal
go
market
week
age
pig
becom
pork
month
old
cattl
sheep
frequent
becom
someon
dinner
month
age
even
belov
pet
rare
live
beyond
teen
year
touch
upon
uniqu
challeng
exist
optim
vaccin
protocol
practic
veterinari
vaccinolog
follow
page
divid
lifestag
protect
provid
mother
unborn
anim
critic
ensur
deliveri
healthi
offspr
livestock
produc
new
anim
gener
incom
farm
result
use
vaccin
pregnanc
wide
adopt
enhanc
protect
utero
fetu
protect
environ
pathogen
protect
provid
physic
immunolog
dam
physic
part
easi
see
fetal
membran
fluid
shield
fetu
behind
muscular
uterin
wall
insid
multilay
abdomen
immunolog
protect
likewis
sever
level
innat
acquir
immun
dam
fetu
unlik
physic
protect
immunolog
protect
may
continu
beyond
utero
period
earli
life
immun
mother
may
prevent
infect
reach
fetu
may
enabl
dam
provid
immun
cell
antibodi
fetu
vaccin
mother
commonli
practic
accomplish
speci
litter
common
exampl
pig
vaccin
dam
effect
way
protect
entir
litter
singl
vaccin
dose
even
singl
offspr
dam
exampl
cattl
vaccin
recogn
provid
ad
insur
get
healthi
newborn
also
effect
way
neonat
anim
gain
earli
immun
plethora
infecti
challeng
face
first
week
life
evid
activ
vaccin
fetu
may
occur
antigen
cross
placenta
stimul
fetal
immun
sow
gestat
period
day
often
vaccin
near
time
breed
week
prior
farrow
vaccin
proven
effect
increas
litter
size
growth
perform
descamp
et
al
vaccin
earli
pregnanc
aim
protect
litter
stimul
activ
immun
sow
common
pathogen
caus
abort
metriti
stillbirth
exampl
leptospira
spp
parvoviru
erysipelothrix
rhusiopathia
vaccin
typic
given
inject
induc
activ
immun
respons
sow
prevent
viremia
bacteremia
occur
thu
protect
unborn
piglet
vaccin
late
pregnanc
aim
boost
immun
maxim
level
passiv
immun
transplacent
colostr
antibodi
dam
pass
offspr
typic
vaccin
target
neonat
diseas
caus
enter
eg
rotaviru
e
coli
respiratori
problem
eg
pasteurella
multocida
bordetella
bronchiseptica
piglet
born
vaccin
sow
gener
perform
significantli
better
nonvaccin
sow
evalu
varieti
paramet
growth
averag
daili
weight
gain
riis
et
al
similar
vaccin
protocol
use
dairi
cattl
sow
vaccin
pregnanc
prevent
abort
help
ensur
birth
healthi
calf
turn
success
birth
calf
also
ensur
anoth
lactat
cycl
dairi
late
pregnanc
vaccin
expect
gener
high
level
circul
antibodi
may
pass
onto
newborn
anim
via
colostrum
colostrum
first
milk
produc
mammal
babi
typic
produc
day
consumpt
newborn
seen
import
varieti
reason
research
shown
matern
antibodi
may
concentr
colostrum
level
higher
found
dam
circul
pfeffer
et
al
use
dam
vaccin
specif
level
antibodi
manipul
tailor
protect
appropri
geograph
region
environ
birth
occur
matern
antibodi
directli
absorb
newborn
enter
circul
provid
passiv
immun
otherwis
fatal
infect
good
evid
cell
cytokin
dam
immun
system
also
pass
via
colostrum
newborn
compon
colostrum
significantli
aid
develop
neonat
immun
result
transient
febril
reaction
decreas
implant
embryo
vaccin
late
pregnanc
close
parturit
tend
less
effect
around
time
parturit
welldescrib
phenomenon
reduc
immun
system
activ
houdijk
et
al
vaccin
may
deliv
expect
efficaci
given
suboptim
condit
even
vaccin
work
well
induc
strong
immun
respons
dam
may
downsid
passiv
antibodi
whether
transplacent
colostr
inhibit
activ
immun
newborn
case
block
effect
last
month
unfortun
level
passiv
immun
block
vaccin
strain
may
suffici
protect
virul
pathogen
gap
lack
protect
earliest
abil
vaccin
well
describ
canin
parvoviru
mcgavin
vaccin
dam
elimin
problem
actual
shift
problem
time
period
risk
exposur
diseas
greater
exampl
young
anim
taken
market
albert
einstein
said
middl
difficulti
lie
opportun
prenat
vaccin
everi
challeng
becom
opportun
vaccin
produc
continu
seek
safer
effect
vaccin
divers
approach
improv
safeti
enorm
ever
increas
regulatori
hurdl
rather
true
safeti
issu
make
vaccin
carri
warn
use
pregnant
anim
true
benefit
prenat
vaccin
enabl
consist
activ
immun
develop
unborn
anim
mani
neonat
diseas
would
disappear
activ
immun
present
birth
result
increas
health
benefit
would
signific
vaccin
readili
avail
present
ovo
vaccin
chicken
perhap
except
although
even
pathogen
cover
safe
effect
ovo
vaccin
system
muneta
et
al
reber
et
al
corollari
colostrum
depriv
anim
typic
numer
health
problem
frequent
infect
matern
antibodi
cross
placenta
protect
unborn
anim
level
transfer
depend
natur
placenta
typic
domest
speci
dog
cat
provid
greatest
utero
transplacent
transfer
antibodi
pig
hors
cattl
provid
greatest
colostr
antibodi
transfer
tizard
tabl
even
poultri
get
benefit
prenat
vaccin
ovo
vaccin
common
vaccin
variou
type
inject
directli
egg
day
age
depend
organ
use
vaccin
whole
process
autom
enabl
mani
thousand
egg
vaccin
day
end
result
hatch
young
bird
protect
select
pathogen
research
shown
ovo
vaccin
may
advantag
posthatch
vaccin
rautenschlein
haas
cours
downsid
prenat
vaccin
vaccin
safe
given
pregnant
anim
administr
live
adjuv
vaccin
pregnanc
carri
risk
induc
transient
febril
reaction
subsequ
abort
stillbirth
may
follow
fever
typic
live
bovin
herpesviru
vaccin
na
cow
associ
abort
due
fetal
infect
vaccin
strain
similarli
live
porcin
reproduct
respiratori
viru
vaccin
found
reduc
litter
size
caus
abort
sow
choic
vaccin
use
pregnant
anim
alway
come
read
label
understand
risk
involv
time
administr
play
larg
part
influenc
safeti
effect
vaccin
vaccin
soon
breed
shown
reduc
concept
rate
probabl
direct
likewis
improv
efficaci
would
highli
desir
help
overcom
periparturi
relax
immun
occur
dam
increas
efficaci
would
result
greater
consist
transplacent
colostr
immun
transfer
develop
product
could
enhanc
transfer
passiv
immun
neonat
would
greatli
welcom
leav
protect
uteru
neonat
begin
deal
plethora
new
antigen
environment
infecti
unfortun
domest
speci
born
rel
immatur
immun
system
inclin
toward
respons
morein
et
al
earli
week
life
birth
newborn
anim
vulner
vaccin
benefici
use
husbandri
practic
use
mani
anim
speci
often
entail
mix
anim
varieti
sourc
exampl
combin
week
old
pig
perhap
hundr
litter
move
nurseri
mix
hundr
puppi
week
age
transport
pet
shop
combin
young
anim
divers
diseas
background
immun
system
yet
fulli
develop
yet
prime
vaccin
huge
challeng
maintain
good
health
need
vaccin
commingl
anim
essenti
reduc
suffer
diseas
outbreak
caus
longer
tri
vaccin
litter
tri
vaccin
dam
anim
individu
albeit
perhap
still
part
larger
group
possibl
directli
administ
vaccin
anim
accord
assess
individu
need
anim
breeder
expect
make
money
sell
offspr
individu
anim
monetari
valu
enabl
fairli
object
view
taken
risk
benefit
analysi
benefit
aris
use
vaccin
versu
cost
diseas
anim
breeder
tailor
vaccin
program
need
anim
multipl
inject
differ
vaccin
common
typic
neonat
anim
receiv
multipl
vaccin
cover
major
diseas
owner
expect
may
becom
expos
live
kitten
could
receiv
eight
differ
vaccin
two
three
separ
occas
although
mani
given
combin
felin
herpesviru
felin
caliciviru
felin
panleukopenia
felin
leukemia
viru
rabi
viru
chlamydia
common
felin
immunodefici
viru
b
bronchiseptica
toxoplasma
gondii
also
avail
cat
puppi
vaccin
often
involv
combin
contain
protect
differ
diseas
agent
exampl
canin
parvoviru
distemp
canin
adenoviru
type
canin
parainfluenza
rabi
viru
four
differ
leptospira
speci
b
bronchiseptica
vaccin
usual
given
time
interv
week
start
week
life
one
consequ
vaccin
individu
anim
larg
number
task
prove
daunt
labor
logist
vaccin
chicken
piglet
quit
involv
fortun
vaccin
avail
mass
administr
optim
deal
larg
flock
herd
sever
option
exist
aerosol
spray
drink
water
common
vaccin
typic
live
agent
dilut
water
contain
stabil
prolong
inus
viabil
agent
aerosol
vaccin
tailor
particular
vaccin
adjust
droplet
size
turn
alter
locat
within
respiratori
tract
droplet
eventu
lodg
gough
allan
gomez
correa
origin
develop
poultri
vaccin
aerosol
vaccin
use
swine
nielsen
et
al
cattl
kita
et
al
factor
poultri
need
consid
droplet
size
type
diluent
environment
condit
eg
wind
temperatur
strain
dose
vaccin
organ
drink
water
vehicl
mass
vaccin
anim
pioneer
poultri
use
speci
addit
vaccin
regular
tap
water
effect
way
vaccin
provid
chlorin
neutral
addit
skim
milk
kim
spradbrow
like
aerosol
vaccin
number
dose
requir
adequ
protect
conting
type
agent
vaccin
age
anim
vaccin
young
anim
pose
numer
challeng
none
difficult
overcom
interfer
matern
immun
matern
deriv
antibodi
young
born
acquir
colostrum
consumpt
protect
level
wane
period
longer
protect
prove
wors
health
young
anim
residu
antibodi
may
block
effect
immun
associ
poor
immun
respons
littl
doubt
newborn
goe
mani
stress
first
week
life
cours
routin
environment
stressor
temperatur
air
qualiti
etc
often
critic
anim
dietari
chang
includ
wean
earli
age
routin
domest
speci
pig
exampl
may
wean
week
age
shown
composit
starter
diet
particular
level
protein
lysin
methionin
threonin
may
critic
develop
immun
system
yongq
et
al
nonneck
et
al
simpl
event
handl
young
anim
enabl
vaccin
shown
stress
potenti
reduc
respons
vaccin
even
car
trip
veterinarian
offic
may
stressrel
effect
immun
system
unfortun
simpli
look
young
anim
possibl
determin
respons
vaccin
nearli
alway
guess
often
result
administr
multipl
dose
vaccin
cover
poor
respond
largest
opportun
improv
vaccin
neonat
juvenil
anim
undoubtedli
vaccin
would
consist
work
face
matern
immun
health
financi
benefit
would
immens
could
remov
need
revaccin
young
anim
activ
immun
block
residu
wane
passiv
immun
conveni
know
could
take
pup
kitten
veterinarian
immun
need
vaccin
herd
piglet
immens
likewis
sustain
releas
longact
vaccin
could
facilit
less
handl
anim
henc
less
stress
longlast
vaccin
would
increas
likelihood
vaccin
antigen
present
anim
abl
respond
abil
test
respons
anim
vaccin
actual
administ
vaccin
could
huge
practic
benefit
anim
owner
especi
livestock
produc
larg
number
anim
vaccin
current
laboratori
test
antibodi
level
possibl
cost
time
make
rel
impract
proven
cheaper
vaccin
hope
respons
bleed
test
abil
determin
perhap
via
simpl
animalsid
test
whether
anim
respond
vaccin
would
benefici
tradit
solut
administ
multipl
dose
around
period
matern
deriv
protect
wane
time
accur
known
even
guarante
suscept
period
numer
paper
testifi
canin
parvoviru
epidem
mani
puppi
fail
protect
despit
receiv
vaccin
weekli
interv
mcgavin
similar
situat
exist
domest
speci
result
mani
dose
vaccin
given
young
anim
ineffect
problem
vaccin
time
deliveri
use
inject
administ
vaccin
proven
effect
deliveri
method
caus
problem
transmiss
diseas
use
contamin
needl
vaccin
vial
document
witter
fadli
niskanen
lindberg
good
hygien
prevent
problem
field
condit
anim
vaccin
frequent
occur
often
conduc
maintain
sanitari
condit
presenc
blood
mud
fece
fli
unexpect
meatproduc
anim
use
needl
deliv
product
lead
anoth
problembroken
needl
meat
product
inabl
find
broken
needl
quit
often
result
condemn
carcass
keep
food
chain
problem
product
includ
medicin
deliv
inject
vaccin
repres
common
reason
stick
needl
meatproduc
anim
rel
immatur
newborn
immun
system
anoth
challeng
must
factor
vaccin
neonat
juvenil
anim
bia
respons
neonat
morein
et
al
alway
prefer
type
immun
respons
protect
diseas
use
adjuv
drive
immun
respons
may
requir
confirm
effect
protect
demonstr
neonat
calv
may
abl
develop
cellmedi
respons
compar
adult
although
antibodi
respons
markedli
lower
seen
adult
heifer
nonneck
et
al
normal
healthi
young
anim
varieti
situat
young
immun
system
even
less
readi
respond
vaccin
colostrum
depriv
anim
matur
immun
system
may
delay
lack
exposur
specif
compon
first
milk
vaccin
colostrumdepriv
anim
undertaken
care
recogn
respons
may
compromis
compar
anim
receiv
colostrum
likewis
stress
consider
progress
made
avoid
needl
deliveri
vaccin
altern
rout
aerosol
drink
water
last
year
develop
needleless
injector
activ
area
research
devic
use
varieti
approach
commonli
involv
high
pressur
forc
liquid
vaccin
directli
skin
without
needl
injector
effect
extent
challeng
deal
superfici
skin
contamin
problem
pose
presenc
dens
hair
coat
obtain
good
skin
contact
inject
hamper
adopt
like
reliabl
highli
effect
needleless
inject
devic
avail
within
next
year
mani
issu
surround
vaccin
neonat
juvenil
anim
tend
resolv
age
adulthood
gener
bring
matur
immun
system
includ
fulli
function
innat
immun
time
vari
speci
gener
year
age
domest
speci
near
breed
age
consid
young
adult
state
earlier
chicken
pig
may
well
gone
slaughter
year
age
breed
anim
speci
kept
beyond
year
age
valu
adult
rear
care
perhap
year
mean
econom
vaccin
gener
less
concern
multipl
vaccin
often
given
consid
specif
diseas
risk
environment
factor
part
tailor
vaccin
program
adult
anim
matur
immun
system
absenc
matern
deriv
immun
adjust
environment
stressor
normal
best
candid
vaccin
even
near
ideal
candid
vaccin
number
dose
requir
efficaci
depend
natur
vaccin
vaccin
fall
broadli
one
two
categori
live
kill
live
vaccin
typic
replic
host
henc
deliv
larg
antigen
mass
immun
system
result
rapid
strong
immun
live
vaccin
sever
advantag
formul
without
specif
immun
system
stimul
gener
caus
less
inject
site
reaction
even
inject
advantag
retain
infect
wildtyp
pathogen
enabl
effect
deliveri
rout
aerosol
oral
one
potenti
neg
replic
risk
immunocompromis
individu
may
induc
sign
diseas
meant
prevent
kill
vaccin
might
better
term
nonrepl
cover
vaccin
never
aliv
exampl
subunitcontain
vaccin
vaccin
categori
made
cultur
live
organ
inactiv
kill
use
one
varieti
chemic
formaldehyd
commonest
inactiv
organ
often
stimul
weak
transient
immun
respons
numer
caus
phenomenon
common
explan
inactiv
alter
conform
henc
present
antigen
epitop
inactiv
antigen
signal
quit
danger
anim
immun
system
danger
signal
model
immun
move
away
self
versu
nonself
base
view
consid
idea
immun
system
concern
organ
damag
anim
rather
foreign
gallucci
matzing
overcom
shortcom
addit
adjuv
classic
done
stimul
greater
immun
respons
drive
particular
immun
respons
exampl
versu
kill
vaccin
safe
without
live
agent
final
product
sourc
infect
howev
presenc
adjuv
often
result
greater
inject
site
reaction
seen
live
vaccin
inject
site
reaction
rang
mere
discomfort
quit
pain
livestock
often
end
imperfect
meat
result
trim
loss
slaughter
line
rout
vaccin
often
dictat
natur
inject
site
reaction
beef
cattl
vaccin
given
subcutan
avoid
reaction
damag
meat
show
anim
exampl
hors
intramuscular
inject
prefer
avoid
blemish
subcutan
inject
may
caus
typic
adult
fall
one
two
categori
respect
vaccin
na
preexpos
true
na
adult
problem
matern
deriv
antibodi
block
effect
vaccin
normal
respond
well
vaccin
fact
respons
vaccin
much
predict
strength
protect
engend
reliabl
percentag
anim
respond
na
adult
anim
critic
adult
anim
tend
adventur
often
travel
greater
contact
anim
particularli
true
companion
anim
speci
dog
cat
hors
may
go
show
board
facil
sport
event
venu
opportun
interact
anim
sign
diseas
concern
owner
issu
howev
tend
seen
commonli
adult
reason
may
easili
understood
rememb
longer
anim
live
vaccin
event
like
live
good
respect
develop
immun
may
downsid
transient
lame
may
occur
follow
vaccin
dose
administ
leg
neck
muscl
may
notic
adult
simpli
greater
weight
anim
compar
neonat
juvenil
counterpart
prior
exposur
vaccin
may
induc
hypersensit
compon
bovin
serum
albumin
use
manufactur
product
result
larger
inject
site
reaction
may
occur
reaction
arthropathi
vascul
neurolog
dysfunct
thrombocytopenia
associ
repeat
vaccin
exposur
schattner
fibrosarcoma
cat
link
vaccin
reaction
usual
fatal
outcom
hershey
et
al
nonetheless
incid
postvaccin
reaction
rel
rare
one
studi
reaction
rate
million
dog
receiv
million
dose
vaccin
found
less
dog
moor
et
al
use
vaccin
period
lactat
found
occasion
caus
transient
decreas
milk
product
scott
et
al
milk
drop
appear
associ
febril
respons
particular
follow
administr
live
viral
vaccin
cattl
milk
product
loss
typic
small
readili
notic
dilig
dairi
staff
adult
anim
often
subject
stress
condit
younger
anim
spare
whether
stress
lactat
stress
perform
race
pull
wagon
result
samepotenti
downregul
immun
system
reduc
respons
vaccin
move
companion
anim
toward
longer
durat
immun
trend
like
expand
vaccin
livestock
labor
cost
handl
matur
livestock
consider
yet
cost
diseas
outbreak
financi
devast
produc
sever
promis
area
vaccin
research
rais
likelihood
longer
durat
immun
anim
speci
vaccin
research
tap
trend
human
health
improv
effect
anim
vaccin
use
dna
vaccin
specif
cytotox
lymphocyt
antigen
cpg
motif
divers
rang
geographi
consequ
diseas
background
enorm
even
livestock
speci
grow
older
greater
exposur
risk
stock
movement
common
introduc
anim
whether
breed
add
product
capac
frequent
come
market
mix
anim
commonplac
diseas
transmiss
preval
onset
durat
immun
occur
vaccin
na
anim
gener
repres
primari
immun
respons
respons
tend
slower
reach
protect
level
memori
may
shorter
follow
singl
vaccin
dose
preexpos
adult
may
alreadi
experienc
diseas
prior
vaccin
histori
often
two
event
indistinguish
without
accur
histori
anim
fortun
come
vaccin
matter
recoveri
infect
effect
previou
vaccin
engend
immun
memori
provid
exposur
long
ago
durat
immun
follow
exposur
immun
system
diseas
agent
even
vaccin
strain
depend
translat
least
part
initi
respons
memori
respons
presenc
specif
memori
cell
enabl
amnest
respons
regardless
sourc
agent
induc
origin
respons
phenomenon
leverag
adult
vaccin
program
decreas
frequenc
revaccin
tradit
dog
cat
revaccin
annual
basi
throughout
lifetim
although
anticip
routin
vaccin
like
provid
far
greater
year
protect
recent
work
proven
field
condit
evid
immun
persist
month
anim
mouzin
et
al
mouzin
et
al
evid
hors
cattl
would
indic
durat
immun
follow
vaccin
may
long
year
vari
diseas
agent
hannant
et
al
peter
et
al
vaccin
manufactur
normal
provid
guidanc
durat
immun
may
anticip
follow
success
vaccin
anim
depend
individu
circumst
durat
immun
may
longer
shorter
label
indic
especi
environ
exposur
diseas
agent
occur
result
natur
boost
immun
essenti
lifelong
immun
like
younger
counterpart
varieti
problem
may
associ
vaccin
exampl
inject
site
reaction
mild
transient
found
induc
potent
memori
respons
kennedi
et
al
anoth
promis
area
research
involv
tlr
receptor
famili
transmembran
protein
interact
varieti
antigen
microbi
organ
activ
interact
tlr
induc
intracellular
cascad
result
select
gene
express
associ
immun
system
discoveri
tlr
agonist
ligand
may
result
new
class
adjuv
specif
yet
safer
incorpor
vaccin
interleukin
gene
code
popular
area
veterinari
research
intent
coadministr
antigen
cytokin
result
enhanc
immun
product
come
market
like
also
benefit
neonat
anim
cytokin
may
help
matur
immun
system
summari
magic
solut
optim
vaccin
program
anim
solid
understand
anim
innat
environment
risk
factor
well
variabl
stress
enabl
develop
tailor
vaccin
schedul
best
meet
need
anim
vaccin
effect
circumst
care
consider
use
certainli
enhanc
chanc
success
protect
anim
final
els
fail
read
label
follow
manufactur
recommend
base
extens
research
provid
help
optim
effect
vaccin
direct
indirect
impact
infecti
diseas
particularli
highli
contagi
diseas
human
anim
health
may
becom
rapidli
massiv
erod
nation
economi
within
hour
day
effect
may
exponenti
natur
diseas
zoonot
trade
sensit
exampl
recent
intern
crisi
outbreak
high
pathogen
avian
influenza
schudel
lombard
reduc
trade
hall
neg
impact
economi
sever
nation
across
globe
southeast
asia
western
europ
mcquiston
et
al
vallat
mallet
addit
human
morbid
mortal
seriou
social
disrupt
gust
et
al
diseas
especi
transboundari
diseas
includ
nipah
viru
west
nile
viru
sever
acut
respiratori
syndrom
sar
von
overbeck
classic
swine
fever
porcin
reproduct
respiratori
syndrom
prr
garner
et
al
rinderpest
pest
de
petit
rumin
ppr
rift
valley
fever
rvf
brucellosi
bovin
tuberculosi
identifi
profound
effect
intern
trade
nation
economi
introduc
countri
free
diseas
domenech
et
al
model
analys
immun
tuberculosi
hiv
chlamydia
trachomati
malaria
effect
vaccin
predict
signific
health
econom
benefit
bishai
mercer
frick
et
al
mair
et
al
classic
exampl
highli
contagi
anim
diseas
sever
impact
intern
trade
caus
social
disrupt
profound
repercuss
nation
global
economi
foot
mouth
diseas
fmd
mccauley
et
al
krystynak
charleboi
perri
et
al
paarlberg
et
al
randolph
et
al
belton
vallat
mallet
unfortun
occur
unit
kingdom
samuel
knowl
thompson
et
al
loss
attribut
fmd
agricultur
food
chain
unit
kingdom
amount
billion
fmd
ongo
crisi
sever
countri
continu
pose
seriou
threat
fmdfree
countri
base
upon
signific
risk
accident
intent
introduct
zoonot
nonzoonot
diseas
newer
strategi
develop
countermeasur
respons
grow
global
crise
associ
known
emerg
unknown
infecti
diseas
man
anim
robust
diseas
model
surveil
system
develop
assess
risk
identifi
potenti
target
vaccin
research
develop
howev
comprehens
interoper
dataset
middlewar
improv
microand
macrolevel
model
requir
make
system
effici
effect
gust
et
al
sever
model
indic
vaccin
strategi
fmd
respiratori
pathogen
justifi
bate
et
al
bate
et
al
bate
et
al
pourbohloul
et
al
even
sophist
fmd
predict
model
method
perez
et
al
perez
et
al
branscum
et
al
shiilegdamba
et
al
accompani
implement
government
polici
need
place
take
tactic
review
data
sever
sourc
lutticken
et
al
found
increas
demand
food
enlarg
scale
world
food
product
augment
transport
anim
food
product
simultan
contact
anim
environ
sever
microorgan
establish
farm
anim
although
may
rel
harmless
anim
pathogen
man
investig
propos
option
reduc
risk
transfer
zoonot
agent
anim
particularli
farm
anim
man
specif
appli
veterinari
vaccin
viral
bacteri
diseas
lutticken
et
al
investig
document
avian
influenza
west
nile
viru
bartonella
hensela
rabi
anthrax
vaccin
protect
anim
reduc
prevent
transmiss
zoonos
human
capua
lutticken
et
al
marano
et
al
miguen
vaccin
vector
reservoir
speci
efficaci
vaccin
avail
offer
offer
signific
advantag
combat
zoonot
human
diseas
zinsstag
weiss
marano
et
al
summari
appropri
bioprepared
manag
strategi
conting
plan
futur
westergaard
link
protect
diva
vaccin
clavijo
et
al
selk
et
al
zoonos
effect
predict
model
branscum
et
al
deploy
implement
polici
kobayashi
et
al
control
prevent
seriou
zoonot
diseas
man
anim
becom
achiev
local
state
nation
level
